ロード中...
Rare diseases and orphan drugs: Latvian story
BACKGROUND: Ten years have passed since Latvia became a Member State of the EU in 2004. As a result European regulations, including those related to rare diseases and orphan drugs, have been applied to Latvian legislative system. Orphan diseases have been recognized as a priority area for action in...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4172941/ https://ncbi.nlm.nih.gov/pubmed/25231378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-014-0147-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|